- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Omacetaxine Mepesuccinate
Total 25 results
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedSolid Tumors | Hematologic MalignanciesNetherlands
-
Teva Branded Pharmaceutical Products R&D, Inc.Cephalon; ChemGenex PharmaceuticalsCompletedChronic Myeloid LeukemiaUnited States, Canada, France, Germany, Hungary, India, Italy, Poland, Singapore, United Kingdom
-
The University of Hong KongCompletedAML | FLT3-ITD MutationHong Kong
-
Teva Branded Pharmaceutical Products R&D, Inc.Cephalon; ChemGenex PharmaceuticalsCompletedChronic Myeloid LeukemiaUnited States, Canada, France, Germany, Hungary, India, Italy, Poland, Singapore, United Kingdom
-
The University of Hong KongUnknownAML | FLT3-ITD MutationHong Kong
-
Teva Branded Pharmaceutical Products R&D, Inc.TerminatedChronic Myeloid LeukemiaUnited States, Belgium, France, Korea, Republic of
-
National Cancer Institute (NCI)CompletedChildhood Chronic Myelogenous Leukemia | Chronic Phase Chronic Myelogenous Leukemia | Relapsing Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
Ge ZhengRecruitingAcute Myeloid LeukemiaChina
-
ChemGenex PharmaceuticalsTerminatedMyeloid Leukemia, Chronic, Chronic-Phase | Myeloid Leukemia, Chronic | Myeloid Leukemia, Chronic, Accelerated-Phase | Blast PhaseUnited States
-
National Cancer Institute (NCI)CompletedLeukemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingHematopoietic and Lymphoid Cell Neoplasm | Recurrent Acute Myeloid Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Myelodysplastic Syndrome | Recurrent Acute Biphenotypic Leukemia | Refractory Acute Biphenotypic LeukemiaUnited States
-
University of Illinois at ChicagoTeva Pharmaceuticals USATerminatedAcute Myeloid LeukemiaUnited States
-
National Cancer Institute (NCI)CompletedChronic Phase Chronic Myelogenous Leukemia | Chronic Myelogenous Leukemia, BCR-ABL1 PositiveUnited States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); Teva Pharmaceutical Industries, Ltd.TerminatedAcute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Completed
-
ChemGenex PharmaceuticalsCompleted
-
Emory UniversityTeva Pharmaceuticals USATerminated
-
University of Illinois at ChicagoRecruitingRelapsed or Refractory Hematologic MalignanciesUnited States
-
M.D. Anderson Cancer CenterTeva Pharmaceuticals USACompleted
-
M.D. Anderson Cancer CenterTeva Pharmaceuticals USATerminated
-
University of Colorado, DenverActive, not recruitingHigh Grade Myelodysplastic SyndromesUnited States
-
University of FloridaTeva Pharmaceutical Industries, Ltd.WithdrawnMyelodysplastic SyndromesUnited States
-
M.D. Anderson Cancer CenterCephalonCompleted
-
Peking University People's HospitalRecruitingHER2-negative Early Breast CancerChina